Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Gadoxetic acid
Подписчиков: 0, рейтинг: 0
Clinical data | |
---|---|
Trade names | Eovist |
Other names | Gadoxetate disodium (USAN US) |
AHFS/Drugs.com | International Drug Names |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank |
|
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C23H30GdN3O11 |
Molar mass | 681.75 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
Gadoxetic acid is a gadolinium-based MRI contrast agent. Its salt, gadoxetate disodium, is marketed as Primovist in Europe and Eovist in the United States by Bayer HealthCare Pharmaceuticals.
Medical uses
It is used to increase the T1 signal intensity while imaging the liver lesions such as benign cysts, haemangioma, and liver cancer. It is excreted into bile by active secretion.
Pharmacokinetics
In those with end-stage renal failure, the clearance rate is only 17% with terminal half-life of 12 times longer than the those with normal renal function.
See also
External links
- "Gadoxetic acid". Drug Information Portal. U.S. National Library of Medicine.
- "Gadoxetate disodium". Drug Information Portal. U.S. National Library of Medicine.
X-ray and CT |
|
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MRI |
|
||||||||||||
Ultrasound |
|
||||||||||||
|